PET imaging targeting CXCR4 has the potential to distinguish different molecular subtypes of Small Cell Lung Cancer Tumors

被引：0
|
作者：
Luo, Yuxi [1 ,2 ]
Pei, Jinli [3 ]
Liu, Jie [4 ,5 ]
Yu, Jinming [4 ,5 ]
机构：
[1] Shandong Univ, Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol,Canc Ctr,Shandong Prov Key Lab, Jinan, Peoples R China
[2] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Coll Clin Med, Luzhou, Peoples R China
[3] Shandong Univ, Shandong First Med Univ, Shandong Acad Med Sci,Shandong Prov Key Lab Radia, Shandong Canc Hosp & Inst,Canc Ctr,Dept Radiat On, Jinan 250117, Shandong, Peoples R China
[4] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol & Shandong Prov Key Lab Radiat, Jinan, Peoples R China
[5] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Shandong Prov Key Lab Radiat Oncol, Jinan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242522
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
    Miodrag Dragoj
    Zorica Milosevic
    Jasna Bankovic
    Nikola Tanic
    Milica Pesic
    Tijana Stankovic
    Cellular Oncology, 2017, 40 : 47 - 62
  • [42] Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer
    Al Zobair, Alya A.
    Al Obeidy, Barrak F.
    Yang, Lei
    Yang, Chunxu
    Hui, Yang
    Yu, Haltun
    Zheng, Fang
    Yang, Guifang
    Xie, Conghua
    Zhou, Fuxiang
    Zhou, Yunfeng
    ONCOLOGY REPORTS, 2013, 29 (04) : 1524 - 1532
  • [43] Molecular determinants of CXCR4 trafficking dictate the metastatic potential in breast cancer
    Fruhwirth, Gilbert O.
    Brock, Adrian
    Keppler, Melanie
    Khan, Abid
    Giamperi, Silvia
    Sahai, Erik
    Gillet, Cheryl
    Archibald, Steve J.
    Ameer-Beg, Simon
    Ng, Tony
    CANCER RESEARCH, 2011, 71
  • [44] Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors
    Hanaoka, Hirofumi
    Mukai, Takahiro
    Tamamura, Hirokazu
    Mori, Tomohiko
    Ishino, Seigo
    Ogawa, Kazuma
    Iida, Yasuhiko
    Doi, Ryuichiro
    Fujii, Nobutaka
    Saji, Hideo
    NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (04) : 489 - 494
  • [45] The ability of SDF-1/CXCR4 axis to proliferation adhesion and invasion of small lung cancer cell
    Huang, Jian An
    Chen, Tao
    Mu, Chuan Yong
    Gu, Yuan Zeng
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [46] Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer
    Wei Guo
    Qilin Huai
    Bolun Zhou
    Lei Guo
    Li Sun
    Xuemin Xue
    Fengwei Tan
    Qi Xue
    Shugeng Gao
    Jie He
    Cancer Immunology, Immunotherapy, 2023, 72 : 1029 - 1045
  • [47] Comprehensive analysis of the immunological implication and prognostic value of CXCR4 in non-small cell lung cancer
    Guo, Wei
    Huai, Qilin
    Zhou, Bolun
    Guo, Lei
    Sun, Li
    Xue, Xuemin
    Tan, Fengwei
    Xue, Qi
    Gao, Shugeng
    He, Jie
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (04) : 1029 - 1045
  • [48] The role of the CXCL12/CXCR4 axis in the immunotherapy of non-small cell lung cancer
    Rogado, Jacobo
    Pozo, Fernando
    Troule, Kevin
    Pacheco, Maria
    Adrados, Magdalena
    Miguel Sanchez-Torres, Jose
    Al-Shahrour, Fatima
    Aspa, Javier
    Alfranca, Arantzazu
    Romero-Laorden, Nuria
    Colomer, Ramon
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [49] CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer
    Tu, Zhenbo
    Xie, Songping
    Xiong, Meng
    Liu, Yinchu
    Yang, Xiangyong
    Tembo, Kingsley Miyanda
    Huang, Jie
    Hu, Weidong
    Huang, Xiaoxing
    Pan, Shan
    Liu, Pan
    Altaf, Ehtisham
    Kang, Ganjun
    Xiong, Jie
    Zhang, Qiuping
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (02) : 505 - 514
  • [50] The role of the CXCL12/CXCR4 pathway in the immunotherapy of non-small cell lung cancer
    Rogado, J.
    Pozo, F.
    Troule, K.
    Pacheco, M.
    Adrados, M.
    Torres, J. M. Sanchez
    Al-Shahrour, F.
    Alfranca, A.
    Laorden, N. Romero
    Bosch, R. Colomer
    ANNALS OF ONCOLOGY, 2023, 34
12345